| Timothy H Lind, MD | |
|
401 Phalen Blvd, Saint Paul, MN 55130-5302 | |
| (651) 254-7560 | |
| (651) 254-7564 |
| Full Name | Timothy H Lind |
|---|---|
| Gender | Male |
| Speciality | Allergy/immunology |
| Experience | 45 Years |
| Location | 401 Phalen Blvd, Saint Paul, Minnesota |
| Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1891760690 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 207K00000X | Allergy & Immunology | 29768 (Minnesota) | Primary |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Healthpartners Medical Group | 1759293954 | 1430 |
News Archive
Resilience—understood as the set of personal resources that help individuals deal effectively with adversity, protecting them from the negative health effects of stress—is receiving increasing attention from researchers.
Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.
The American Dietetic Association supports a report released today by the Institute of Medicine calling for a standardized system for front-of-package food labeling that can be easily understood by most consumers.
GlaxoSmithKline and XenoPort, Inc. announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved Horizant™ (gabapentin enacarbil) Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome in adults. Horizant is not recommended for patients who are required to sleep during the daytime and remain awake at night.
› Verified 3 days ago
| Entity Name | Group Health Plan Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1710924683 PECOS PAC ID: 1759293954 Enrollment ID: O20031105000417 |
News Archive
Resilience—understood as the set of personal resources that help individuals deal effectively with adversity, protecting them from the negative health effects of stress—is receiving increasing attention from researchers.
Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.
The American Dietetic Association supports a report released today by the Institute of Medicine calling for a standardized system for front-of-package food labeling that can be easily understood by most consumers.
GlaxoSmithKline and XenoPort, Inc. announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved Horizant™ (gabapentin enacarbil) Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome in adults. Horizant is not recommended for patients who are required to sleep during the daytime and remain awake at night.
› Verified 3 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Timothy H Lind, MD 8170 33rd Ave S, Ms 21110q, Bloomington, MN 55425-4516 Ph: () - | Timothy H Lind, MD 401 Phalen Blvd, Saint Paul, MN 55130-5302 Ph: (651) 254-7560 |
News Archive
Resilience—understood as the set of personal resources that help individuals deal effectively with adversity, protecting them from the negative health effects of stress—is receiving increasing attention from researchers.
Aradigm Corporation today announced it is presenting data on September 22, 2010, from its Phase 1 studies at the ERS Annual Congress in Barcelona, Spain. The podium presentation elaborates on the pharmacokinetic parameters of ciprofloxacin in the blood and sputum samples that were observed in the healthy volunteers and non-cystic fibrosis bronchiectasis (BE) patients.
The American Dietetic Association supports a report released today by the Institute of Medicine calling for a standardized system for front-of-package food labeling that can be easily understood by most consumers.
GlaxoSmithKline and XenoPort, Inc. announced Wednesday that the U.S. Food and Drug Administration (FDA) has approved Horizant™ (gabapentin enacarbil) Extended-Release Tablets for the treatment of moderate-to-severe primary Restless Legs Syndrome in adults. Horizant is not recommended for patients who are required to sleep during the daytime and remain awake at night.
› Verified 3 days ago
John Geoffrey Wahlstrom, M.D. Allergy & Immunology Medicare: Medicare Enrolled Practice Location: 565 Snelling Ave S, Saint Paul, MN 55116 Phone: 651-698-0386 Fax: 651-698-0483 | |
Anthony Charles Orecchia, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1020 Bandana Blvd W, Saint Paul, MN 55108 Phone: 651-241-9700 | |
Dr. Niladri Aichbhaumik, MD Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 565 Snelling Ave S, Saint Paul, MN 55116 Phone: 651-698-0386 Fax: 651-698-0483 | |
Dr. Sarah Margaret Nicolai, M.D. Allergy & Immunology Medicare: Accepting Medicare Assignments Practice Location: 401 Phalen Blvd, Saint Paul, MN 55130 Phone: 651-254-7560 Fax: 651-254-7564 | |
William Emmett Walsh, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 1690 University Ave W, Suite 450, Saint Paul, MN 55104 Phone: 651-645-8182 Fax: 651-649-3509 | |
Dr. Gary Richard Geller, M.D. Allergy & Immunology Medicare: Not Enrolled in Medicare Practice Location: 565 Snelling Ave S, Saint Paul, MN 55116 Phone: 651-698-0386 Fax: 651-698-0483 |